Several institutions and organizations including our own are advancing the research of anti-inflammatory drugs as treatment methods for depression and depressive symptoms. Read about it at Nature.
Neuroinflammation is rapidly being tied to a number of physical and cognitive health issues, presenting a new direction for potential treatments.
Dr. Miller spoke with Dave Asprey on his Podcast, Bulletproof radio, to discuss inflammation’s effects on aging. Listen to it here.
How can you maintain your motivation during stressful times? Our research provides one answer. See more at Inc.
Christopher Bergland takes a look at our research on inflammation and motivation at Psychology Today.
Computational modeling provides a new look at chronic, low grade inflammation’s effects on motivation. Read more at Medical Express.
Inflammation research at Emory helps develop our understanding of treatment-resistant depression. Dr. Miller discusses this research with Healio.
Dr. Sarah Gingell analyzes an unexpected question with the help of our recent findings. Read about it in Psychology Today.
Infliximab, an anti-inflammatory, could be a new avenue for depression treatment. Our study is outlined in Psychiatric Times.
Dr. Xiao sheds light on HPV-unrelated squamous cell carcinoma of the head and neck and how it relates to various aspects of fatigue and inflammation in a recent study. Read more at Healio.